SecreFlo (secretin)
/ Repligen, 9 Meters Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 16, 2022
Secretin-Assisted Computed Tomography Scan and Magnetic Resonance Imaging in Improving Pancreatic Tumor Conspicuity
(clinicaltrials.gov)
- P1 | N=0 | Withdrawn | Sponsor: University Hospitals Cleveland Medical Center | N=40 ➔ 0 | Unknown status ➔ Withdrawn
Enrollment change • MRI • Trial withdrawal • Gastrointestinal Cancer • Hepatology • Oncology • Pancreatic Cancer • Solid Tumor
1 to 1
Of
1
Go to page
1